Marcela Holmes
SHARE

A big threat or nature’s next step towards the end of the pandemic?

When news came out about the new Omicron variant I went searching for information about its lethality (or otherwise).

While case fatality data isn’t available yet, doctors in South Africa who have been treating people with it have reported that this variant is associated with very mild symptoms. As reported here by Reuters, Dr. Angelique Coetzee said that patients with this variant do not have the typical COVID clinical picture, with the symptoms instead being fatigue, body aches and headache for a few days. “Most of them are seeing very, very mild symptoms and none of them so far have admitted patients to surgeries. We have been able to treat these patients conservatively at home,” she said. It’s also primarily affecting the under 40s.

The Law of Declining Virulence vs. the Trade-Off Model

It’s been a long-accepted theory that some pathogens evolve to make them more transmissible and the same time less deadly – they sort of evolve into a more benign relationship with the host. Is this what we are seeing with the O variant?

However, declining virulence is not a given. There are examples of old diseases that may be just as virulent today as they ever were. The trade-off theory states that there are a range of factors that determine virulence for each pathogen or strain, including, for example the length of time between infection and death or recovery, as this affects opportunities for spread. This means that it’s more complicated than the law of declining virulence suggests, and variants may evolve to become either more or less virulent.

We know that coronaviruses are apt to mutate easily; most mutations die out quickly and come to nothing. There needs to be an evolutionary advantage for a strain to become an established variant. It is interesting that Omicron appears to be significantly more transmissible than Delta, as it means it has the potential to displace Delta as the dominant strain if it gets a foothold. If, as early cases suggest, Omicron is more mild in its effects across the population, and if it becomes a dominant strain, that could be a good thing. But a caveat at this point – an increase in transmissibility can somewhat blunt the positive effect of a decreased case fatality rate if it spreads at high speed but is still killing a small number of the most vulnerable.

If … if … if. I know. Well, my crystal ball isn’t working terribly well – let’s face it, no-one knows what’s going to happen. But while the focus is on panic, close the borders, will the vaccines protect? … I thought I’d provide another perspective.

Leave A Comment